Erectile Dysfunction Drugs 2020 Global Market Key Players, Analysis and Forecast to 2023

  Erectile Dysfunction Drugs Market Overview: 

The global market for erectile dysfunction drugs market is set to cross a valuation of USD 2930million by 2023 with a CAGR of 3.5% during the forecast period (2018-2023). Market Research Future revealed several factors like a rising recording of cases of erectile disorder, increasing geriatric population, expiry of patents of major blockbuster drugs, and better drug development as major reasons behind the growth of the erectile dysfunction drugs market. Growth in the sedentary lifestyle may also boost the demand for such drugs.  

However, patients often fail to adhere to these drugs in proper terms, which can restrain the growth of this erectile dysfunction drug market growth.  

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/1313

Erectile Dysfunction Drugs Market Segmentation: 

The global erectile dysfunction drugs market share, on account of MRFR experts, has been segmented based on drugs and end users. This segmentation is expected to reveal insight related to dynamics, growth factors, and demographic challenges. These insights will be further backed by figures received after detailed analysis.  

By drug, the global market on the erectile dysfunction drugs has been segmented into Cialis (tadalafil), staxyn/Levitra (vardenafil), viagra (sildenafil citrate), zydena (udenafil), vitaros (alprostadil cream), stendra/spedra (avanafil), and others. Viagra has a huge market share as it is the first-of-its-kind drug that received the approval of the FDA in 1998. Cialis is expected to make a better impact on the market in terms of growth as its erection period is higher than that of Viagra.  

By end user, the global market for erectile dysfunction drugs has been segmented into retail pharmacy, hospital pharmacy, and online pharmacy. The retail pharmacy segment is expected to benefit from the easy availability of drugs. The segment is the largest one. Hospitals are expected to gain more from growing awareness and are expected to be the fastest one in terms of growth.  

Erectile Dysfunction Drugs Market Regional Analysis: 

The Americas are set to dominate the global erectile dysfunction drugs market. This is primarily due to the rising presence of major drug companies and the increasing adoption of various new technologies to treat the disorder. Also, the growing awareness regarding the disorder is expected to boost the market profit. In Asia Pacific, rising awareness and the massive population are expected to play in favor of the market.  

Erectile Dysfunction Drugs Market Competitive Landscape: 

Global erectile dysfunction drugs market is expected to get boosted by the strategic developments launched by companies like Apricus Biosciences Inc., Bayer AG, Pfizer, Inc., Dong-A Pharmaceutical Co. Ltd., Cristalia Produtos Quimicos Farmaceuticos Ltd., Meda Pharmaceuticals, Inc., Eli Lilly and Company, Vivus, Inc., S.K. Chemicals Co. Ltd., Teva Pharmaceutical Industries Ltd., and others. These companies are showing an intent to take the global market forward by constantly indulging in various strategic discussions where they are working on mergers, acquisitions, collaborations, hike in investment for research and development, branding strategies, distribution channels, and others. MRFR’s recording of all the latest proceedings is expected to improve the scope of market study.  

Industry News: 

In May 2020, a report revealed that the global market for erectile dysfunction drugs market had witnessed a price fall in both generic and branded drugs between July 2019 and January 2020. But the price of branded drugs has bounced back after February 2020. The report is on the basis of a close analysis of several online drug supply chain. One of the major reasons behind this price change is COVID-19. The rise in home delivery services has changed the market expectations and the price is getting impacted by that.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/erectile-dysfunction-drugs-market-1313 

 

China IUCD 2020 Global Market Key Players, Analysis and Forecast to 2023

  Market Scenario:

IUCD stands for Intra-Uterine Contraceptive Devices. It is a device inserted into the uterus to prevent pregnancy. The device is T-shaped made up of flexible plastic with a coating of thin copper wire. China, ICUD was the most important tool to limit the couples to have one child. One child policy of China was introduced in 1979 favored the growth of this market till 2015. But in January 2016, a new law named “Two-child policy” become effective, which was passed by standing committee of National People’s Congress in December 2016. According to census 2010, the population change in is 7.39 per year. The market for IUCD is showing a steady rise in China because most of the women still do not want to have a second child even after the passage of second child policy. China IUCD market growth is expected to reach USD 20 billion in 2023 from USD 14 billion in 2016 with a CAGR of approximately 8.72% during the forecast period 2017-2023.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/1306 

Study objectives:

• Main objective of this research is to provide information about IUCD market, types of provider services and payer services.
• To provide detailed analysis of the market structure along with forecast for the next seven years of the various segments and sub-segments of the IUCD market.
• To provide insights about factors affecting the market growth.
• To analyze the IUCD based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to China
• To provide country level analysis of the market with respect to the current market size and future prospective.
• To provide country level analysis of the market for segments by diagnosis and by end users and its sub-segments.
• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the China IUCD market. 

Key Players
SMB Corporation Of India, Bayer HealthCare Pharmaceuticals Inc. (US), Mona Lisa (Belgium), Teva Women’s Health, DKT International (US).

Segmentation:
The market for IUCD in China is segmented into types which include hormonal IUD, copper IUD and other types. The end users are hospitals, Clinics and others.

Regional Analysis:
On the basis of regions market for IUCD in China is segmented into North China, Northeast China, East China, South Central China, Southwest China and Northwest China. East China account for the largest market share. It has the highest population and largest population density. The market in China is showing steady growth due to an increase in the population in all the regions.

Intended Audience

• Healthcare IT companies
• Healthcare companies
• Contract Research Organizations (CROs)
• Research and Development (R&D) Companies
• Academic Medical Institutes and Universities

The report for IUCD of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/china-iucd-market-1306 

 

Global Contrast Media Market Research Report 2020 Analysis and Forecast to 2025

 Contrast Media Market Insight

The contrast media/ contrast agents market is making significant strides over recent years, mainly due to the rapidly developing medical imaging technologies. Besides,strong headways in terms of product developments and their approvals drive the growth of the market. The healthcare sector is burgeoning and medical imaging technology & techniques are advancing profusely. These advancements have improved the utilization of the existing contrast media while presenting innovative agents. This, in turn, escalates the market to furthered height. 

According to Market Research Future (MRFR), the Global Contrast Media Market size is estimated to increase exponentially by 2025, registering approximately 3.5% CAGR during the review period (2019 – 2025). Increasing uses of contrast media in medical imaging to enhance the visibility of blood vessels & GI tract support the growth of the market. Moreover, rising numbers of contrast media approvals act as a key tailwind pushing the market forward. Simultaneously, the rising expectations of radiologists augment market demand.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1284  

Additionally, the rising prevalence of various chronic diseases such as GIT, cancer, cardiac conditions, and an increase in the number of public as well as private diagnostic centers are fostering market growth. Also, the demand for improved diagnostic imaging services and various diagnostic imaging modalities are creating substantial market demand. On the flip side, the risk of side / adverse effects of the contrast media is impeding the market growth. However, technological innovations would support the contrast media market growth, improving media functionalities.

Contrast Media Market Major Players

Players active in the global contrast media market include NanoScan Imaging (US), Bayer Healthcare Pharmaceuticals (Germany), Daiichi (Japan), Medrad Inc. (US), Guerbet Group (France), Subhra Pharma Private Limited (India), GE Healthcare (US), nanoPET Pharma GmbH (Germany), Covidien (Ireland), AMAG Pharmaceuticals (US), CMC Contrast AB (Sweden), Targeson (US), Mallinckrodt Pharmaceuticals (UK), Lantheus Medical Imaging (US), and Bracco Diagnostic Inc. (Italy), among others. 

Global Contrast Media Market – Segments

The analysis has been segmented into six main dynamics.

• By Type: Iodinated Contrast Media and Gadolinium-Based Contrast Media, and others.
• By Form:Tablet, Powder, Liquid, and Paste.
• By Procedure: Computed Tomography, X-ray, Ultrasound, Magnetic Resonance Imaging, and other procedures.
• By Application: Oncology, Cardiovascular Disorders, Nephrological Disorders, and others.
• By Route of Administration: Injectable, Oral, and Rectal.
• By Regions:Asia Pacific, North America, Europe, and the Rest-of-the-World. 

Global Contrast Media Market – Geographical Analysis

North America dominates the global contrast media market. The largest market share majorly attributes to the advancements in the medical & imaging technologies. Furthermore, the increasing prevalence of chronic diseases and massive uptake of advanced technologies for the diagnosis of myriad diseases & disorders drive the regional market growth. The presence of notable players and their increasing emphasis on delivering cost-competitive product range foster the growth of the contrast media market in the region.

Europe accounts for the second-largest market share in the global contrast media market. Increasing healthcare expenditures and the adoption of advanced technologies boost regional market growth.  Also, the presence of many global players in the region is another key driving the growth of the regional market.  Additionally, the growth of the medical supplies market in the region fosters the European contrast media market. 

The Asia Pacific region is becoming a profitable market for Contrast Medias, globally. Factors such as the rapidly increasing healthcare sectors and developing economy in the region are pushing the growth of the market. Besides, profusely developing APAC countries such as India, Japan, and China, contribute to the regional market growth, significantly. Also, the rising population and spreading awareness for the functionalities of contrast media influence the market growth in the APAC region.

Global Contrast Media Market – Competitive Analysis

The market appears highly competitive and diversified with the presence of several well-established players. To gain a larger competitive advantage in the market, players adopt strategies such as mergers & acquisitions, expansion, collaboration, and product & technology launch. They make substantial R&D investments in developing new products and manufacturing technology. 

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/contrast-media-market-1284

Nurse Call System Market to Witness an Outstanding Growth by 2023

 Recently MRFR, a leading market research firm collated a novel report on “Global Nurse Call System Market Research Study” that gives comprehensive market overview about the current market dynamics with a focus on the worldwide market.

Nurse Call System Market growth analysis by top global leaders, size, share, market segmentations, products statistics, 2019 sales, brands, manufacturers and Nurse Call System Industry forecast to 2023 – Nurse Call System Market leading US, Australia and UK region with healthy revenue. 

Global Nurse Call System Market is expected to grow significantly over the forecast period. It is estimated that the Nurse Call System Market is expected to register a CAGR ~ 9.5 % during the forecast period from 2018 to 2023. 

Nurse Call System Market – Sketch 

Nurse Call System is a communication system used in healthcare facilities to alert nurses in cases of medical emergencies and the need for care. These systems are also useful for tracking a patient, especially in the care home or old age centers and can also be used to give instructions and notifications during the events of ambulatory services. Rapidly growing population and prevalent diseases & disorders worldwide demand advanced medical infrastructures such as assisted living centers.

Also Read : https://www.medgadget.com/2019/09/nurse-call-system-market-size-share-trends-dynamics-potentials-top-manufacturers-industry-drivers-leading-regions-and-forecast-to-2023.html 

Besides, large hospitals & clinics that are often confronted with the complexities of the operations prompt the demand for effective nurse call systems provide smooth care services. As a result, the nurse call system market is growing rapidly on a global platform, witnessing a constant product demand. According to a leading research firm – Market Research Future (MRFR), the global nurse call system market is expected to gain significant accruals by 2023.

In its recently published study, MRFR also asserts that the market would register a CAGR over 9.5 % throughout the forecast period (2018 – 2023).  The emergence of rapidly evolving IoT (internet of things) in the field of wired & wireless technology is predominantly driving market growth. Additionally, other factors that contribute to market growth include increasing geriatric population, urbanization, and improving economic situations in the countries across the globe.

The market is growing due to the proliferation of cloud & IoT devices. Advancements in network & connectivity technologies are fostering the growth of the market, increasingly bringing down prices of these devices. The negligible cost of scalability of communication is providing impetus to the growth of the market to an extent.

Conversely, high costs associated with the installation & maintenance and lack of awareness towards benefits of these nurse call systems are impeding the growth of the market. Also, concerns of privacy and data breaches due to the open nature of the network are key factors obstructing the market growth.

Prominent Companies – Nurse Call System Market

Key industry contributors mentioned in the report include

• CSINC,
• AMETEK, Inc.,
• Ascom,
• Johnson Controls.,
• Vigil Health Solutions Inc.,
• BEC Integrated Solutions, LLC,
• Hill-Rom Services Inc.,
• Austco Communication Systems Pty Ltd.,
• West-Com Nurse Call System, Inc,
• Cornell Communications,
• Azure Healthcare,
• STANLEY Healthcare,
• Systems Technologies,
• Jeron Electronic Systems Inc.,
• Honeywell International Inc.,

Fiercely competitive, the nurse call system market appears to be fragmented characterized by the presence of numerous small & large players. To gain a substantially large revenue pocket, these players incorporate various strategic initiatives such a

Segments – Nurse Call System Market

The report is segmented into five market dynamics to widen the scope of understanding,

By Type: Nurse Call Buttons, Integrated Communication Systems, Mobile Systems, and Intercoms, among others.

By Technology: Wired Systems and Wireless Systems.

By Application: Medical Emergency, Alarms, and Workflow Management, among others.

By End-users:  Hospitals & Nursing Homes, Assisted Living Centers, and Ambulatory Care Centers, among others.

By Regions: Asia Pacific, North America, Europe, and the Rest-of-the-World.

Industry Updates

September 05, 2019 — B. Braun Medical Inc. (the US), a leader in infusion therapy & pain management, and manufacturer of innovative medical products & services, announced the successful integration of its Space™ infusion pump systems with alert systems of West-Com Nurse Call Systems, Inc. West-Com is involved in the development of advanced nurse call systems that can improve patient care outcomes, contributing to the patient care environment, positively. Therefore, these systems can successfully enrich the lives of patients, family members, and healthcare staff members. This is yet another important milestone for B. Braun in its mission to make it easier for its customers to standardize patient care.

September 05, 2019 — CIBC Private Wealth Group, LLC (the US), a provider of investment management services announced that it has acquired a new stake in shares of Vocera Communications Inc (the US), a leading global provider of nurse call systems and others. The institutional investor acquired 10,015 shares of the communications equipment provider’s stock, valued at approximately USD 320,000.

April 01, 2019 – Critical Alert Systems, LLC (the US) a leading enterprise-class patient communications application developer, announced the completion of its acquisition of Sphere3® Consulting. The new company will deliver an Integrated, Leading-Edge Patient Communication and Experience Management Platform. Critical Alert Systems offers highly flexible and scalable enterprise-grade Patient Communications and Nurse Call solution on the market. Sphere3’s award-winning patient analytics platform, Aperum®, tracks and correlates patient perception and behavior based on nurse call and rounding activities.

Regional Analysis – Nurse Call System Market

North America region would retain its dominance over the global nurse call system market throughout the forecast period, acquiring the largest market share. Factors, such as the presence of a large number of key players and state-of-the-art infrastructure that allows development and early uptake of advanced technologies drive the regional market growth.

Well-developed economies, the US and Canada, lead the regional nurse call system market due to the extensive uptake of advanced communication systems in a large number of medical infrastructures. Additionally, increased funding invested in improving healthcare infrastructure in this region, alongside the high healthcare expenses are the dominating forces behind the growth in the regional market.

The nurse call system market in the European region stands at the second position in terms of the size of the market. The presence of well-developed healthcare infrastructure and rising geriatric population in the region foster the market growth in the region.  Increasing uptake of these systems for the care of increasing numbers of patients suffering from chronic diseases drive the regional market growth, commutatively. Besides, the availability of funds from the public and private bodies to drive the research and development boost the growth of the regional market.

The Asia Pacific nurse call system market is emerging as a profitable market, growing rapidly at a global level. APAC countries such as India, China, South Korea, and Japan, are at the forefront in the regional nurse call system market. Heading with the huge technological advancements in the rapidly proliferating healthcare sector, the region is poised to register a substantially high CAGR throughout the forecast period (2017-2023). Besides, rising expenditures on the improvement of healthcare infrastructure and increasing the patient population foster the growth of the regional market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/upcoming-reports/nurse-call-system-market-5631 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Cardiac pacemaker Market Estimated to Witness a Staggering Growth by 2023

 Cardiac pacemaker Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.

Global Cardiac Pacemaker Market has been expanding with the rising burden of cardiac diseases and increasing need for cardiac rhythm management. Factors like atrial fibrillation and rising geriatric population is creating a robust growth scope for cardiac pacemaker market. By 2025 the global geriatric population is expected to surpass 2.1 billion. However, older people are more active now than they ever used to be and activities like swimming, jogging and riding bikes to stay fit are activities most people above the age of 50 indulge in and are recommended to pursue by doctors. However, disorders like cardiac arrhythmia can pose a significant hindrance to such activities and therefore more people are turning to cardiac implants like pacemakers to live a more active life. Assessments by Market Research Future affirms that cardiac pacemaker market is expecting a 7.9% CAGR over 2018-2023.

Also Read : https://www.medgadget.com/2019/11/cardiac-pacemaker-market-top-10-companies-analysis-by-size-industry-share-statistics-growth-factors-business-strategies-trends-and-forecast-to-2023.html 

Cardiac pacemaker industry giants are also investing immensely in the development of enhanced pacemaker technologies to augment their position in the market. For instance, Medtronic created ripples in the cardiac pacemaker market when it launched the smallest pacemaker in the world. Micra, as the device is called was approved by the U.S. FDA in 2016 and is a part of Medtronic’s deep miniaturization program. It is a leadless pacemaker and is implanted directly into the patient’s heart and the minimally invasive surgery makes it possible to go back to daily activities within two days.

Cardiac pacemaker market to accrue substantial growth as incidence of cardiac arrhythmia proliferates

Technological advancements in pacemaker technology to act as major driving factor for cardiac pacemaker market

Rising geriatric population around the world to stimulate cardiac pacemaker market growth

Segmentation:

Cardiac pacemaker market is segmented on the basis of type, application, technology and end-users.

On the basis of type cardiac pacemaker market is further subdivided as external cardiac pacemaker, implantable and others.

By technology cardiac pacemaker market is classified into dual-chambered, single-chambered, biventricular and others.

Application-wise segmentation of cardiac pacemaker market comprises congestive heart failure, arrhythmias and others. Arrhythmias segment is further subdivided bradycardia, tachycardia and others.

End user segmentation of cardiac pacemaker market includes cardiac care centers, hospitals, medical institutes and others

Industry News:

Cardiac pacemaker market trends have been strengthened by continuous research and development endeavors that have been undertaken for the advancement of the technology. Recently researchers in China developed a pacemaker that can be powered by the beating motion of the heart. Batteries in pacemakers last between 5 to 12 years. After that they have to be removed surgically to replace them. Surgeries can often lead to complications, infections and bleeding thus putting patient’s life at risk. The revolutionary pacemaker being developed by researchers in Institute of Cardiothoracic Surgery at Changhai Hospital, has been tested on pigs and has shown promise for the development of battery-less cardiac pacemaker in the future.

Competitive Insight:

There are several significant players in the Cardiac Pacemaker Companies such as Medtronic, BIOTRONIK, Boston Scientific Corporation, Abbott, MEDICO S.p.A., SORIN Group, LEPU MEDICAL, OSCOR Inc. etc. Most of these companies are investing heavily in research and development activities that can lend an added competitive edge to them. On the other hand, they are also undertaking strategic moves and investing in merger, acquisition and collaborations to gain an expanded share in the cardiac pacemaker market. Pacemaker Companies in India are on new highs with increase in demand of pacemaker in India.

Regional Analysis:

Geographically cardiac pacemaker market is subdivided into Americas, Europe, APAC and MEA. The Americas is expected to lead the cardiac pacemaker market due to the presence of better healthcare policies and superior infrastructure. Rising geriatric population has created a significant demand for cardiac pacemakers in the region. Lifestyle diseases that are leading to increased cardiac disorders and increased expenditure for better health are factors adding impetus to North America cardiac pacemaker market.

Europe cardiac pacemaker market is anticipated to account for the second largest revenue share due to increased government spending on enhancing the healthcare sector. Research and development activities seeking better and more efficient solution to cardiac disorders is expected to augment market growth in the region.

With emerging economies like China and India investing in healthcare infrastructure improvement, APAC region is slated to witness the fastest growing cardiac pacemaker market. Also, medical tourism in Asian countries has been on the rise which has led to increased infrastructure development for medical centers and in turn led to significant growth in the cardiac pacemaker market.

The MEA cardiac pacemaker market is expected to record slower growth due to lack of infrastructure and economic backwardness of the region.

About Market Research Future:

Market Research Future® has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Our Research Analysts are eager to share their knowledge and assist you in refining market research parameters, choosing right market studies, and evaluating both the market scope and the research methodologies of varied segments.

We bridge the gap between our clients and their clients by identifying and decoding just the target group, while generating leads with the highest accuracy.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/cardiac-pacemaker-market-2025 

Contact Us:

Market Research Future (MRFR)

528, Amanora Chamber

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Global Robotics Prosthetics Market Expected to Grow with a healthy CAGR

 Robotic prosthetics Market report by MRFR contains all analytical and statistical transient regarding Market summary, Growth, Demand and Forecast analysis with penetrating summary and solution within the complex industry.

Robotics Prosthetics Market Information: By-Products (Prosthetic Arms, Prosthetic Feet/Ankles), Technology (Bluetooth, Myoelectric Technology) Application (Lower Body, Upper Body Extremity) And End Users (Hospitals, Clinics) – Global Forecast till 2027 

Robotics Prosthetics Market – Scenario

Robotic prosthetics are artificial limbs which combine the prosthetics with robotics to offer fully functional prosthetics which allow patients to carry out normal functions with their artificial limbs. This factor alone has boosted the robotic prosthetics market. Market Research Future’s survey of the global robotics prosthetics market has found that the growth of the market is anticipated at a CAGR of 9.5% during the forecast period from 2016 to 2027.

Also Read : https://www.medgadget.com/2019/04/robotics-prosthetics-market-key-reasons-for-the-present-growth-demand-and-upcoming-business-opportunity-with-detailed-foreseen-to-2023.html

Robotics prosthetics represent immense promise for advanced medical technology, which is in high demand. Medical advancements are being achieved at a rapid pace, and the ability of robotics prosthetics to promote normal limb function after the loss of a natural limb is in high demand. The increasing prevalence of various chronic diseases which can result in limb loss is a key factor driving the growth of the global market. The expanding geriatric population is another driver of the global robotics prosthetics market — increasing cases of fragility fractures combined with an increase in awareness regarding innovative medical technology. Increasing spending on healthcare as well as investments in R&D in the advancement of existing technology are some other factors contributing to the growth of the market.

Robotic prosthetics are not well covered in insurance reimbursement policies which has been a challenge to the adoption of robotic prosthetics. Moreover, robotics prosthetics are expensive, which makes them inaccessible, thus restraining market growth.

Regional Analysis

The Americas which comprise of North America and South America are also subdivided into various country level markets. Among these, the U.S leads growth for the Americas regional robotics prosthetics market. The regions high prevalence of orthopedic diseases has resulted in the high demand for robotic prosthetics. High healthcare investments and the presence of a developed healthcare sector which has an affinity toward the adoption of advanced technology are some other factors driving market growth. Notably, Mexican Americas have a high risk for osteoporosis and as such are vulnerable to bone issues that may result in a need for robotic prosthetics.

Europe is a significant market which has a strong affinity toward R&D as evidenced by government support, via encouraging regulations. The high availability for funds toward investments in R&D is driving the growth of the robotics prosthetics market.

The Asia Pacific is a highly promising market due to its sheer size. The region has an immense patient population with growing awareness regarding advanced medical technology. The presence of a rapidly expanding geriatric population is a key driver of the market. The region’s healthcare sector is undergoing heavy reforms as well as witnessing increasing investments. Increasing demand among patients for high-quality treatment options is driving international market players to focus on the region. The region also significant in the medical tourism market and as such is likely to attract more patients as the quality of healthcare improves.

Market Segmentation

The Robotics Prosthetics Market has been segmented in MRFR’s report on the basis of product, application, technology, end-user, and region. Products available in the robotics prosthetics market include prosthetic hands, prosthetic legs & knees, prosthetic arms, prosthetics feet/ankles, and others.

Technology employed in robotic prosthetics include Bluetooth, microprocessor knees, myoelectric technology, prosthetic foot materials, and others.

Applications of robotic prosthetics are divided between lower body extremities and upper body extremities.

End users of robot prosthetics include hospitals, clinics, and others.

Key Players in the Robotics Prosthetics Market:

The Global Robotics Prosthetics Market is highly fragmented with the presence of many local players and international players. The main focus of these players is cost reduction and innovation to ensure sustainability. In addition, the international players implemented growth strategies through collaborations and partnerships to expand their overall market share.

SynTouch, LLC, Transenterix, Inc., Intuitive Surgical, Inc., Touch Bionics Inc., Mazor Robotics Ltd., Stryker Corporation, HDT Global Inc, Medrobotics Corporation, Hansen Medical, Inc., KUKA Roboter GmbH, ZOLL Medical Corporation, Smith & Nephew, ReWalk Robotics, Aethon, and Shadow Robot Company

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/robotics-prosthetics-market-1316 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Osteoarthritis Market to Perceive Momentous Accruals with a hefty CAGR By 2023

 Osteoarthritis Market report focuses on the key player’s profiles in detail with granular analysis of the market share, production technology, market entry strategies, revenue forecasts and regional analysis of the market.

Osteoarthritis Market is to rise at 6.8% CAGR by 2023, according to Global Osteoarthritis Market Information by Type (Hip Osteoarthritis, Spinal Osteoarthritis) By Diagnosis (Imaging, Joint Fluid Analysis) By Treatment (Medication, Surgery, Therapy) By End Users (Hospitals, Medical Institutes) and Region. The increasing cases of osteoarthritis in the elderly population are the main demand drivers for the Osteoarthritis market.

Osteoarthritis Market Key Players Analyzed for this report:

Novartis AG (Europe), Abbott. (U.S.), Merck Sharp & Dohme Corp. (U.S.), Eli Lilly and Company. (U.S.), ABIOGEN PHARMA S.p.A (Europe), Pfizer Inc. (U.S.), Ampio Pharmaceuticals Inc. (U.S.), Regeneron (U.S.), TissueGene Inc. (U.S.), and others.

Also Read : https://www.medgadget.com/2019/07/osteoarthritis-market-2019-global-analysis-by-size-growth-treatment-key-players-share-trends-revenue-key-country-and-regional-forecast-to-2023.html 

Market Overview:

The rising geriatric and obese population are spurring the detection of osteoarthritis globally. Market reports connected with the healthcare industry have been made available by Market Research Future which generates reports on other business verticals that outlines the current market scenarios. The market is anticipated to develop at a 6.8% CAGR in the forecast period.

The market is expected to benefit from the augmented detection rates and improved accessibility to healthcare facilities where treatment can be sought. Increased investment in developing effective treatment options is anticipated to spur the osteoarthritis market’s growth in the forecast period.

Segmental Analysis:

The Osteoarthritis Market is segmented based on diagnosis, end users, type, and treatment.

Based on type, the osteoarthritis market is segmented into wrist osteoarthritis, spinal osteoarthritis, hip osteoarthritis, and others.

Based on diagnosis, the market is segmented into joint fluid analysis, imaging, and others. The imaging segment is additionally sub-segmented into X-rays, magnetic resonance imaging (MRI), and others.

Based on treatment, the market is segmented into surgery, therapy, medication, and others. The medication segment is sub-segmented into analgesics, non-steroidal anti-inflammatory drugs and others. The analgesics sub-segment, on the basis of medication, is further segmented into acetaminophen, duloxetine, and others. The non-steroidal anti-inflammatory drugs sub-segment, on the basis of medication, is further segmented into naproxen sodium, ibuprofen, naproxen, aspirin, and others.

Based on end users, the osteoarthritis market is segmented into hospitals & clinics, medical institutes, research organization, and others.

Regional Analysis:

The regional analysis of the osteoarthritis market observes that the American region controls the osteoarthritis market due to a strong healthcare sector and strong patient population for osteoarthritis. Apart from these factors, the varying lifestyles and growing healthcare spending have increased the development of the market in the American region. The European region is the next major osteoarthritis market, which is trailed by the Asia Pacific region. The accessibility to funds for research, vast patient population, growing healthcare expenses, well-developed healthcare sector and government backing for research & development are anticipated to boost the market development during the forecast period. Eastern Europe is the fastest mounting region due to the vast opportunities in the unexploited market.

The Asia Pacific region is the fastest rising region in global market owing to the incidence of a vast patient population, constantly developing economies like India and China, and the existence of enormous opportunity in the market. Moreover, promising government policies and growing healthcare expenditures are fuelling the market development within the region. Conversely, the Middle East & African region controls the smallest portion in the osteoarthritis market globally owing to the incidence of a poor economy, particularly, in the African region. The Middle Eastern region holds a majority of the market of this region due to the strong healthcare sector and vast healthcare spending by countries like Saudi Arabia, Kuwait, Dubai, and Qatar.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/osteoarthritis-market-1609 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Company Name: Market Research Future

Email: sales@marketresearchfuture.com

Phone: +1 646 845 9312

Country: India

Website: www.marketresearchfuture.com